Eidos Therapeutics - Ownership and Business Overview

Life ScienceCompany

Eidos Therapeutics Ownership

Who owns Eidos Therapeutics?

Eidos Therapeutics is owned by BridgeBio Pharma. It was acquired on October 5, 2020.

Was Eidos Therapeutics formerly PE-backed?

Yes. Eidos Therapeutics was formerly owned by 1 private investor.

Eidos Therapeutics Business Overview

Where is Eidos Therapeutics headquartered?

Eidos Therapeutics is headquartered in San Francisco, California.

How many employees does Eidos Therapeutics have?

Eidos Therapeutics has 70 employees.

What sector is Eidos Therapeutics in?

Eidos Therapeutics is a life science company.

When was Eidos Therapeutics founded?

Eidos Therapeutics was founded in 2013.

Life Science M&A Summary in 2020

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2020. The largest life science acquisition in 2020 was Alexion Pharmaceuticals - which was acquired by AstraZeneca for $39.0B.

Join Mergr to view all 284 acquisitions of life science companies in 2020, including 23 acquisitions by private equity firms, and 261 by strategics.

Eidos Therapeutics

Eidos Therapeutics, Inc.

101 Montgomery Street Suite 2000,
San Francisco, California 94104
United States,
(415) 887 1471
www.eidostx.com

Eidos Therapeutics is a biopharmaceutical company developing therapies to treat transthyretin amyloidosis (ATTR), primarily in the heart. Eidos Therapeutics was founded in 2013 and is headquartered in San Francisco, California.


 Subscribe to unlock this and 206,577
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 199K M&A Transactions
  • 202K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 80K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.